Wednesday, March 23, 2022

New Clinical Trials for Acute Myeloid Leukemia

New Clinical Trials for Acute Myeloid Leukemia - TC Biopharm (Holdings) PLC announced that it has received MHRA and Research Ethics Committee approvals to initiate gamma-delta T cell therapy clinical trials of OmnImmune® for the treatment of Acute Myeloid Leukemia (AML).       OmnImmune® an allogeneic unmodified cell therapy consisting of activated and expanded gamma delta T cells has already received orphan drug designation for the treatment of patients suffering from the blood and bone marrow cancer.  Phase 2/3 trials will begin enrollment in the first half of 2022 in […] Click here to read: eTurboNews | TravelNews | World Talk
http://dlvr.it/SMGRCb

No comments:

Post a Comment